Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.67
+0.09 (1.61%)
At close: Apr 28, 2026, 4:00 PM EDT
5.78
+0.11 (1.94%)
After-hours: Apr 28, 2026, 7:20 PM EDT
Bausch Health Companies Revenue
In the year 2025, Bausch Health Companies had annual revenue of $10.27B with 6.66% growth. Bausch Health Companies had revenue of $2.80B in the quarter ending December 31, 2025, with 9.26% growth.
Revenue (ttm)
$10.27B
Revenue Growth
+6.66%
P/S Ratio
0.21
Revenue / Employee
$505,714
Employees
20,300
Market Cap
2.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.27B | 641.00M | 6.66% |
| Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
| Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.25B |
| Amneal Pharmaceuticals | 3.02B |
| Phibro Animal Health | 1.46B |
| Prestige Consumer Healthcare | 1.10B |
| ANI Pharmaceuticals | 883.37M |
| BioCryst Pharmaceuticals | 874.84M |
| Supernus Pharmaceuticals | 718.95M |
| HUTCHMED (China) | 548.51M |
BHC News
- 5 days ago - Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration - Business Wire
- 14 days ago - Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering - PRNewsWire
- 20 days ago - Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update - Business Wire
- 21 days ago - Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe - Business Wire
- 4 weeks ago - Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 - PRNewsWire
- 4 weeks ago - Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program - PRNewsWire
- 2 months ago - Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PRNewsWire
- 2 months ago - Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres - PRNewsWire